What is gene therapy and how does it work?

Gene therapy introduces, modifies, or removes genetic material in cells to treat disease. It typically uses a 'vector' (often a modified virus) to deliver a functional gene into target cells, correcting a genetic defect or providing a new therapeutic function.

What are the main types of gene therapy?

The main types are somatic gene therapy, which modifies cells in the patient's body and does not affect offspring, and germline gene therapy, which alters reproductive cells and is generally prohibited due to ethical concerns.

What diseases can be treated with gene therapy?

Gene therapy is used for inherited genetic disorders like SMA, Leber Congenital Amaurosis, thalassemia, and sickle cell disease, as well as certain cancers (e.g., CAR-T therapy) and some infectious diseases.

What are the risks and limitations of gene therapy?

Risks include immune reactions, off-target effects, potential for insertional mutagenesis, and high costs. Limitations involve delivery challenges, transient effects, and ethical dilemmas, especially with germline modification.

Is gene therapy legal in India?

Yes, somatic gene therapy research and clinical trials are legal in India under strict regulatory oversight by the ICMR and CDSCO, following guidelines like the New Drugs and Clinical Trials Rules, 2019. Germline therapy is prohibited.

What is the difference between gene therapy and gene editing?

Gene therapy primarily adds or replaces genes. Gene editing, using tools like CRISPR, precisely alters existing DNA sequences within the genome to correct specific mutations, offering more targeted modifications.

Which gene therapy treatments are approved in India?

As of late 2024, no indigenous gene therapy has received full commercial approval in India. However, several international gene therapies are available via import, and numerous clinical trials are ongoing for various conditions under CDSCO/ICMR oversight.

← ALL TOPICS

Science & Technology

NEXT TOPIC →

Recombinant DNA Technology

Gene Therapy

Science & Technology

Constitution VerifiedUPSC Verified

Version 1Updated 10 Mar 2026

Explore This Topic

Definition Detailed Explanation Key Discoveries Scientific Principles Tech Evolutions UPSC Importance Prelims Strategy Mains Strategy Prelims MCQs Mains Questions MCQ Practice Predicted 2026 Revision Notes Current Affairs

Gene therapy is a medical approach that introduces, removes, or changes genetic material in a patient's cells to treat or prevent disease. This can involve replacing a mutated gene that causes disease with a healthy copy, inactivating a mutated gene that is functioning improperly, or introducing a new gene into the body to help fight a disease. The U.S. Food and Drug Administration (FDA) defines g…

Quick Summary

Gene therapy is a cutting-edge medical intervention that aims to treat diseases by altering a patient's genetic material. Instead of merely managing symptoms, it targets the underlying genetic cause. This involves introducing a healthy gene to replace a faulty one, inactivating a problematic gene, or introducing a new gene to fight disease.

The core mechanism relies on 'vectors,' typically modified viruses like Adeno-associated Viruses (AAVs) or Lentiviruses, which act as delivery vehicles to transport the therapeutic genetic material into specific target cells.

Once delivered, the new gene can produce a missing protein, correct a genetic error, or trigger an immune response against diseased cells. Gene therapy can be categorized into somatic gene therapy, which affects only the treated individual and is generally permitted, and germline gene therapy, which alters reproductive cells and is globally prohibited due to ethical concerns about heritable changes.

Key applications include inherited disorders such as Spinal Muscular Atrophy (SMA) and Leber Congenital Amaurosis (LCA), for which therapies like Zolgensma and Luxturna are approved. It also plays a crucial role in cancer treatment, notably with CAR-T cell therapy where a patient's immune cells are engineered to fight cancer.

While offering immense promise for curative treatments, gene therapy faces significant challenges, including high costs, potential safety risks like immune reactions or unintended genetic alterations, and complex regulatory pathways.

In India, the field is governed by the ICMR and CDSCO, which oversee clinical trials and ensure ethical conduct, aligning with the National Biotechnology Development Strategy 2021–25 to foster indigenous development and address the nation's genetic disease burden.

Vyyuha

Your 6-Month Blueprint, Updated Nightly

AI analyses your progress every night. Wake up to a smarter plan. Every. Single.…

Gene Therapy: Modifies genetic material to treat disease.

Types: Somatic (non-heritable, accepted), Germline (heritable, prohibited).

Vectors: Viral (AAV, Lentivirus, Adenovirus), Non-viral (Liposomes, Nanoparticles, Electroporation).

AAV: Low immunogenicity, infects dividing/non-dividing cells. Examples: Zolgensma (SMA), Luxturna (LCA).

Lentivirus: Integrates into host genome, stable expression. Used in CAR-T.

CAR-T Therapy: Genetically engineered T-cells to fight cancer (Leukemias, Lymphomas).

CRISPR-Cas9: Gene editing tool, precise DNA alteration. Distinct from gene therapy.

Indian Regulators: ICMR (guidelines), CDSCO (approvals).

Key Indian Policy: New Drugs and Clinical Trials Rules, 2019; National Biotechnology Development Strategy 2021–25.

Ethical Concerns: Germline prohibition, high cost, equitable access, informed consent.

Challenges: Safety (immunogenicity, off-target effects), Cost, Delivery efficiency.

Recent Approvals (2023-24): Casgevy (CRISPR for Sickle Cell/Thalassemia) in US/UK.

India's focus: Indigenous R&D, addressing genetic disease burden (Thalassemia, Sickle Cell).

Vyyuha Mnemonic VECTOR: V-Viral, E-Ethical, C-Cost, T-Target, O-Oversight, R-Regulation.

Vyyuha Mnemonic SAGE: S-Somatic, A-Applications, G-Germline, E-Ethics.

Vyyuha Quick Recall Mnemonics:

VECTOR (for key aspects of Gene Therapy):

Viral & Non-viral (Delivery methods)

Ethical Concerns (Germline, Access)

Cost (High, Affordability)

Target Diseases (Inherited, Cancer)

Oversight (ICMR, CDSCO)

Regulation (New Drugs Rules, Guidelines)

SAGE (for types and ethical status):

Somatic (Gene Therapy)

Accepted (Ethically)

Germline (Gene Therapy)

Ethically Prohibited (Globally)

Infographic Suggestion: A visual representation (1200x630 px) depicting the 'VECTOR' mnemonic as a central graphic, with each letter branching out to a small icon and a brief explanatory phrase. For example, 'V' with a virus icon and 'Delivery Methods', 'E' with a scales of justice icon and 'Ethical Dilemmas'.

The 'SAGE' mnemonic could be a smaller inset comparing two figures, one with a 'no' sign for germline and one with a 'yes' for somatic. Alt text: 'Infographic summarizing key aspects of gene therapy using VECTOR and SAGE mnemonics for UPSC revision.

' Caption: 'Vyyuha Quick Recall: Mnemonics for Gene Therapy Essentials.

Gene Therapy

Quick Summary

Related Topics